Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response

Cancer Letters

Volumn 234, Issue 1, 2006, Pages 40-50

  Wada, Morimasa ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

ABC transporter; ABCB1; ABCC2; SNP; Tumorigenesis; Xenobiotics

Indexed keywords

ABC TRANSPORTER;

CARCINOGENESIS; CELLULAR DISTRIBUTION; GENE EXPRESSION; GENE FUNCTION; GENETIC VARIABILITY; HUMAN; INTESTINE TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33644806448     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.06.050     Document Type: Review

References (92)

1. J. Konig, A.T. Nies, Y. Cui, I. Leier, and D. Keppler Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance Biochim. Biophys. Acta 1461 1999 377 394
2. M.M. Gottesman, T. Fojo, and S.E. Bates Multidrug resistance in cancer: role of ATP-dependent transporters Nat. Rev. Cancer 2 2002 48 58
3. P. Borst, R. Evers, M. Kool, and J. Wijnholds A family of drug transporters: the multidrug resistance-associated proteins J. Natl Cancer Inst. 92 2000 1295 1302
4. I.B. Holland S.P.C. Cole K. Kuchler C.F. Higgins ABC Proteins: from Bacteria to Man 2003 Academic Press Amsterdam
5. M. Wada, T. Uchiumi, and M. Kuwano Canalicular multispecific organic anion transporter, ABCC2 S. Bröer C.A. Wagner Membrane Transport Diseases: Molecular Basis of Inherited Transport Defects 2003 Kluwer New York 263 289
6. P. Borst, R. Evers, M. Kool, and J. Wijnholds A family of drug transporters: the multidrug resistance-associated proteins J. Natl Cancer Inst. 92 2000 1295 1302
7. T. Ishikawa, M.T. Kuo, K. Furuta, and M. Suzuki The human multidrug resistance-associated protein (MRP) gene family: from biological function to drug molecular design Clin. Chem. Lab. Med. 38 2000 893 897
8. J. König, A.T. Nies, Y. Cui, D. Keppler, I.B. Holland, and S.P.C. Cole MRP2, the apical export pump for anionic conjugates C.F. Higgins ABC Proteins: from Bacteria to Man 2003 Academic Press Amsterdam 423 443
9. K. Taniguchi, M. Wada, K. Kohno, T. Nakamura, T. Kawabe, and M. Kawakami A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation Cancer Res. 56 1996 4124 4129
10. M. Buchler, J. Konig, M. Brom, J. Kartenbeck, H. Spring, and T. Horie cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats J. Biol. Chem. 271 1996 15091 15098
11. K. Ito, H. Suzuki, T. Hirohashi, K. Kume, T. Shimizu, and Y. Sugiyama Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR rats Am. J. Physiol. 35 1997 G16 G22
12. C.C. Paulusma, P.J. Bosma, G.J. Zaman, C.T. Bakker, M. Otter, and G.L. Scheffer Congenital jaundice in rats with a mutation in a multidrug resistanceassociated protein gene Science 271 1996 1126 1128
13. W. Priebe, M. Krawczyk, M.T. Kuo, Y. Yamane, N. Savaraj, and T. Ishikawa Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump Biochem. Biophys. Res. Commun. 247 1998 859 863
14. D.W. Loe, R.G. Deeley, and S.P. Cole Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione Cancer Res. 58 1998 5130 5136
15. G. Jedlitschky, I. Leier, U. Buchholz, K. Barnouin, G. Kurz, and D. Keppler Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump Cancer Res. 56 1996 988 994
16. T. Ishikawa The ATP-dependent glutathione S-conjugate export pump Trends Biochem. Sci. 17 1992 463 468
17. E. Bakos, R. Evers, J.A. Sinkule, A. Varadi, P. Borst, and B. Sarkadi Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions Mol. Pharmacol. 57 2000 760 768
18. D.W. Loe, K.C. Almquist, R.G. Deeley, and S.P.C. Cole Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles: demonstration of glutathione-dependent vincristine transport J. Biol. Chem. 271 1996 9675 9682
19. D.W. Loe, K.C. Almquist, S.P.C. Cole, and R.G. Deeley ATP-dependent 17-estradiol 17-(-D-glucuronide) transport by multidrug resistance protein: inhibition by cholestatic steroids J. Biol. Chem. 271 1996 9683 9689
20. D.W. Loe, R.K. Stewart, T.E. Massey, R.G. Deeley, and S.P.C. Cole ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the MRP gene Mol. Pharmacol. 51 1997 1034 1041
21. T. Ishikawa, M. Müller, C. Klünemann, U. Berger, L. Lucka, and A. Schreyer ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates J. Biol. Chem. 265 1990 19279 19286
22. R. Evers, N.H. Cnubben, J. Wijnholds, L. Van Deemter, P.J. Van Bladeren, and P. Borst Transport of glutathione prostaglandin a conjugates by the multidrug resistance protein 1 Fed. Eur. Biochem. Soc. Lett. 419 1997 112 116
23. M. Heijn, J.H. Hooijberg, G.L. Scheffer, G. Szabo, H.V. Westerhoff, and J. Lankelma Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport Biochim. Biophys. Acta 1326 1997 12 22
24. J.H. Hooijberg, H.J. Broxterman, M. Heijn, D.L. Fles, J. Lankelma, and H.M. Pinedo Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein Fed. Eur. Biochem. Soc. Lett. 413 1997 344 348
25. G. Jedlitschky, I. Leier, U. Buchholz, J. Hummel-Eisenbeiss, B. Burchell, and D. Keppler ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2 Biochem. J. 327 1997 305 310
26. E.M. Leslie, K.-I. Ito, P. Upadhyaya, S.S. Hecht, R.G. Deeley, and S.P.C. Cole Transport of the β-O-glucuronide conjugate of the tobacco-specific carcinogen 4- (methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1), requirement for glutathione or a non-sulfur-containing analog J. Biol. Chem. 276 2001 27846 27854
27. R. Evers, M. Kool, L. Van, H. Jansen, J. Calafat, and L.C. Oomen Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA J. Clin. Invest. 101 1998 1310 1319
28. C.G. Dietrich, D.R. De Waart, R. Ottenhoff, I.G. Schoots, and R.P. Elferink Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine in MRP2-deficient rats Mol. Pharmacol. 59 2001 974 980
29. C.C. Paulusma, and R. Oude Elferink The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man J. Mol. Med. 75 1997 420 428
30. S.V. Kala, M.W. Neely, G. Kala, C.I. Prater, D.W. Atwood, and J.S. Rice The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic J. Biol. Chem. 275 2000 33404 33408
31. J. Okamura, M. Monden, S. Horikawa, O. Sikujara, G. Kosaki, and K. Seki Hepatocellular carcinoma in a case of Dubin-Johnson syndrome treated successfully with right extended lobectomy Jpn. J. Surg. 10 1980 343 347
32. J.A. Roth, E. Berman, D. Befeler, and F.B. Johnson A black hepatocellular carcinoma with Dubin-Johnson-like pigment and mallory bodies: a histochemical and ultrastructural study Am. J. Surg. Pathol. 6 1982 375 382
33. A. Sakamoto, I. Mori, K. Kawai, and H. Tsuchiyama Dubin-Johnson syndrome associated with hepatocellular carcinoma - report of an autopsy case Gan No Rinsho (Jpn. J. Cancer Clin.) 33 1987 1361 1367
34. P.H. Bernard, J.F. Blanc, C. Paulusma, B. Le, J. Carles, and C. Balabaud Multiple black hepatocellular adenomas in a male patient Eur. J. Gastroenterol. Hepatol. 12 2000 1253 1257
35. Y. Adachi, T. Nanno, and T. Yamamoto Japanese clinical statistical data of patients with constitutional jaundice Nippon Rinsho (Jpn. J. Clin. Med.) 50 1992 677 685 (in Japanese)
36. S. Ueno, G. Tanabe, K. Hanazono, H. Ogawa, S. Yoshidome, and T. Aikou Postoperative management following massive hepatectomy in a patient with Dubin-Johnson syndrome: report of a case Surg. Today 28 1998 1274 1278
37. T. Takino, T. Takahashi, and T. Okuno Clinical study of the constitutional hyperbilirubinemia in Japan. A nationwide survey between 1970 and 1974 Jpn. J. Gastroenterol. 74 1977 1518 1528
38. S. Toh, M. Wada, T. Uchiumi, A. Inokuchi, Y. Makino, and Y. Horie Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATPBinding-cassette region in Dubin-Johnson syndrome Am. J. Hum. Genet. 64 1999 739 746
39. Y. Mochida, K. Taguchi, S. Taniguchi, M. Tsuneyoshi, H. Kuwano, and T. Tsuzuki The role of pglycoprotein in intestinal tumorigenesis: disruption of indula suppresses polyp formation in ApcMin,4 mice Carcinogenesis 24 2003 1219 1224
40. T. Yamada, Y. Mari, R. Hayashi, M. Takada, Y. Ino, and Y. Naishiao Suppression of intestinal polyposis in Mdrl-deficient ApcMin/_ mice Cancer Res. 63 2003 895 901
41. M. Frank, M. Doss, and D.G. De Carvalho Carvalho: diagnostic and pathogenetic implications of urinary coproporphyrin excretion in the Dubin-Johnson syndrome Hepatogastroenterology 37 1990 147 151
42. S. Ito, I. Ieiri, M. Tanabe, A. Suzuki, S. Higuchi, and K. Otsubo Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects Pharmacogenetics 11 2001 175 184
43. S. Saito, A. Iida, A. Sekine, C. Ogawa, S. Kawauchi, and S. Higuchi Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR) J. Hum. Genet. 47 2002 147 171
44. H. Suzuki, and Y. Sugiyama Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition Adv. Drug Deliv. Rev. 54 2002 1311 1331
45. J. Kartenbeck, U. Leuschner, R. Mayer, and D. Keppler Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome Hepatology 23 1996 1061 1066
46. D. Keppler, and J. Kartenbeck The canalicular conjugate export pump encoded by the cmrp/cmoat gene Prog. Liver Dis. 14 1996 55 67
47. C.C. Paulusma, M. Kool, P.J. Bosma, G.L. Scheffer, F. Ter Borg, and R.J. Scheper Mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome Hepatology 25 1997 1539 1542
48. H. Tsujii, J. Konig, D. Rost, B. Stockel, U. Leuschner, and D. Keppler Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome Gastroenterology 117 1999 653 660
49. M. Wada, S. Toh, K. Taniguchi, T. Nakamura, T. Uchiumi, and K. Kohno Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome Hum. Mol. Genet. 7 1998 203 207
50. G. Tate, M. Li, T. Suzuki, and T. Mitsuya A new mutation of the ATP-binding cassette, sub-family C, member 2 (ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome Genes Genet. Syst. 77 2002 117 121
51. V. Keitel, J. Kartenbeck, A.T. Nies, H. Spring, M. Brom, and D. Keppler Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome Hepatology 32 2000 1317 1328
52. R. Mor-Cohen, A. Zivelin, N. Rosenberg, M. Shani, S. Muallem, and U. Seligsohn Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome J. Biol. Chem. 276 2001 36923 36930
53. K. Hashimoto, T. Uchiumi, T. Konno, T. Ebihara, T. Nakamura, and M. Wada Trafficking-defect and functional-defect by mutations of the ATP-binding domains in multidrug resistance protein 2 in patients with Dubin-Johnson syndrome Hepatology 36 2002 1236 1245
54. A.L. Schwartz, and A. Ciechanover The ubiquitin-proteasome pathway and pathogenesis of human diseases Ann. Rev. Med. 50 1999 57 74
55. A.E. Senior, M.K. Al-Shawi, and I.L. Urbatsch The catalytic cycle of P-glycoprotein FEBS: Fed. Eur. Biochem. Soc. Lett. 377 1995 285 289
56. I.L. Urbatsch, B. Sankaran, J. Weber, and A.E. Senior P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site J. Biol. Chem. 270 1995 19383 19390
57. M. Gao, H.R. Cui, D.W. Loe, C.E. Grant, K.C. Almquist, and S.P.C. Cole Comparison of the functional characteristics of the nucleotide binding domains of multidrug resistance protein 1 J. Biol. Chem. 275 2000 13098 13108
58. K. Nagata, M. Nishitani, M. Matsuo, N. Kioka, T. Amachi, and K. Ueda Nonequivalent nucleotide trapping in the two nucleotide binding folds of the human multidrug resistance protein MRP1 J. Biol. Chem. 275 2000 17626 17630
59. L.W. Hung, I.X. Wang, K. Nikaido, P.Q. Liu, G.F. Ames, and S.H. Kim Crystal structure of the ATP-binding subunit of an ABC transporter Nature 396 1998 703 707
60. T. Dork, F. Mekus, K. Schmidt, J. Bosshammer, R. Fislage, and T. Heuer Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patients Hum. Genet. 94 1994 533 542
61. K. Diederichs, J. Diez, G. Greller, C. Muller, J. Breed, and C. Schrell Crystal structure of MalK, the ATPase subunit of the trehalose/maltose ABC transporter of the archaeon thermococcus litoralis Eur. Mol. Biol. Org. J. 19 2000 5951 5961
62. S. Kajihara, A. Hisatomi, T. Mizuta, T. Hara, I. Ozaki, and I. Wada A splice mutation in the human canalicular multispecific organic anion transporter gene causes Dubin-Johnson syndrome Biochem. Biophys. Res. Commun. 253 1998 454 457
63. R.C. Bargou, K. Jurchott, C. Wagener, S. Bergmann, S. Metzner, and K. Bommert Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression Nat. Med. 3 1997 447 450
64. T. Ohga, T. Uchiumi, Y. Makino, K. Koike, M. Wada, and M. Kuwano Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene J. Biol. Chem. 273 1998 5997 6000
65. T. Harada, J. Nagayama, K. Kohno, L.A. Mickley, T. Fojo, and M. Kuwano Alu-associated interstitial deletions and chromosomal re-arrangement in 2 human multidrug-resistant cell lines Int. J. Cancer 86 2000 506 511
66. H. Kusaba, M. Nakayama, T. Harada, M. Nomoto, K. Kohno, and M. Kuwano Association of 5′ CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells Eur. J. Biochem. 262 1999 924 932
67. M. Nakayama, M. Wada, T. Harada, J. Nagayama, H. Kusaba, and K. Ohshima Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias Blood 92 1998 4296 4307
68. Y. Tada, M. Wada, K. Kuroiwa, N. Kinugawa, T. Harada, and J. Nagayama MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment Clin. Cancer Res. 6 2000 4618 4627
69. F. Thiebaut, T. Tsuruo, H. Hamada, M.M. Gottesman, I. Pastan, and M.C. Willingham Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues Proc. Natl Acad. Sci. USA 84 1987 7735 7738
70. I. Sugawara, I. Kataoka, Y. Morishita, H. Hamada, T. Tsuruo, and S. Itoyama Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16 Cancer Res. 48 1988 1926 1929
71. C. Cordon-Cardo, J.P. OlBrien, D. Casals, L. Rittman-Grauer, J.L. Biedler, and M.R. Melamed Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites Proc. Natl. Acad. Sci. USA 86 1989 695 698
72. A.H. Schinkel, U. Mayer, E. Wagenaar, C.A. Mol, L. Van Deemter, and J.J. Smit Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins Proc. Natl Acad. Sci. USA 94 1997 4028 4033
73. A.H. Schinkel Pharmacological insights from P-glycoprotein knockout mice Int. J. Clin. Pharmacol. Ther. 36 1998 9 13
74. S.V. Ambudkar, S. Dey, C.A. Hrycyna, M. Ramachandra, I. Pastan, and M.M. Gottesman Biochemical, cellular, and pharmacological aspects of the multidrug transporter Annu. Rev. Pharmacol. Toxicol. 39 1999 361 398
75. P.B. Watkins The barrier function of CYP3A4 and P-glycoprotein in the small bowel Adv. Drug Deliv. Rev. 27 1997 161 170
76. M.F. Fromm The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans Adv. Drug Deliv. Rev. 54 2002 1295 1310
77. C. Cordon-Cardo, J.P. OlBrien, J. Boccia, D. Casals, J.R. Bertino, and M.R. Melamed Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues J. Histochem. Cytochem. 38 1990 1277 1287
78. E.G. Schuetz, A.H. Schinkel, M.V. Relling, and J.D. Schuetz P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans Proc. Natl Acad. Sci. USA 93 1996 4001 4005
79. B. Greiner, M. Eichelbaum, P. Fritz, H.P. Kreichgauer, O. Von Richter, and J. Zundler The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin J. Clin. Invest. 104 1999 147 153
80. U. Schumacher, and K. Mollgard The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain Histochem. Cell Biol. 108 1997 179 182
81. V.V. Rao, J.L. Dahlheimer, M.E. Bardgett, A.Z. Snyder, R.A. Finch, and A.C. Sartorelli Choroid plexus epithelialexpression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal fluid drug-permeability barrier Proc. Natl Acad. Sci. USA 96 1999 3900 3905
82. F. Thiebaut, T. Tsuruo, H. Hamada, M.M. Gottesman, I. Pastan, and M.C. Willingham Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein J. Histochem. Cytochem. 37 1989 159 164
83. E. Hinoshita, T. Uchiumi, K. Taguchi, N. Kinukawa, M. Tsuneyoshi, and Y. Maehara Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas Clin. Cancer Res. 6 2000 2401 2407
84. S. Hsing, Z. Gatmaitan, and I.M. Arias The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa Gastroenterology 102 1992 879 885
85. R.W. Johnstone, A.A. Ruefli, and M.J. Smyth Multiple physiological functions for multidrug transporter P-glycoprotein? Trends Biochem. Sci. 25 2000 1 6
86. R.S. Weinstein, S.M. Jakate, J.M. Dominguez, M.D. Lebovitz, G.K. Koukoulis, and J.R. Kuszak Relationship of the expression of the multidrug resistance gene product (P- glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis Cancer Res. 51 1991 2720 2726
87. J. Kankesan, R. Vanama, A. Yusuf, J.J. Thiessen, V. Ling, and P.M. Rao Effect of PSC 833, an inhibitor of P-glycoprotein on N-methyl-N-nitrosourea induced mammary carcinogenesis in rats Carcinogenesis 25 2004 425 430
88. J. Kankesan, A. Yusuf, E. Laconi, R. Vanama, G. Bradley, and J.J. Thiessen Effect of PSC 833, an inhibitor of P-glycoprotein, on 1,2-dimethylhydrazine-induced liver carcinogenesis in rats Carcinogenesis 24 2003 1977 1984
89. S. Hoffmeyer, O. Burk, O. Von Richter, H.P. Arnold, J. Brockmoller, and A. Johne Functional polymorphisms of the human multidrugresistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo Proc. Natl Acad. Sci. USA 97 2000 3473 3478
90. S. Taniguchi, Y. Mochida, T. Uchiumi, T. Tahira, K. Hayashi, and K. Takagi Genetic polymorphism at the 5′ regulatory region of MDR1 and its association with inter-individual variation of expression level in colon Mol. Cancer Ther. 2 2003 1351 1359
91. V. Materna, and H. Lage Homozygous mutation Arg768Trp in the ABC-transporter encoding gene MRP2/cMOAT/ABCC2 causes Dubin-Johnson syndrome in a caucasian patient J. Hum. Genet. 48 2003 484 486
92. S. Wakusawa, I. Machida, S. Suzuki, H. Hayashi, M. Yano, and K. Yoshioka Identification of a novel 2026G→C mutation of the MRP2 gene in a Japanese patient with Dubin-Johnson syndrome J. Hum. Genet. 48 2003 425 429